The novel estrogen-responsive B box protein (EBBP) gene is tamoxifen regulated in cells expressing an estrogen receptor DNA-binding domain mutant

Molecular Endocrinology

Volumn 12, Issue 11, 1998, Pages 1733-1748

  Liu, Hsiao Lai C ^a   Golder Novoselsky, Elina ^b   Seto, Marian H ^a   Webster, Lynn ^a   McClary, John ^a   Zajchowski, Deborah A ^a  

^a BAYER AG   (Germany)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR; TAMOXIFEN;

AMINO ACID SEQUENCE; ARTICLE; CELL PROLIFERATION; CHROMOSOME 17P; DNA BINDING; EPITHELIUM CELL; GENE DELETION; GENETIC REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN LOCALIZATION; TUMOR SUPPRESSOR GENE;

EID: 0031754662     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.12.11.0193     Document Type: Article

References (69)

1. McGuire W, Carbone P, Vollmer R 1975 Estrogen Receptors in Human Breast Cancer. Raven Press, New York
2. Zajchowski DA, Sager R 1991 Induction of estrogen-regulated genes differs in immortal and tumorigenic human mammary epithelial cells expressing a recombinant estrogen receptor. Mol Endocrinol 5:1613-1623
3. Stampfer MR, Bartley JC 1985 Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. Proc Natl Acad Sci USA 82:2394-2398
4. Zajchowski DA, Webster L, Humm R, White FA, Simmons SJ, Bartholdi M 1997 Different estrogen receptor structural domains are required for estrogen- and tamoxifen-dependent anti-proliferative activity in human mammary epithelial cells expressing an exogenous estrogen receptor. J Steroid Biochem Mol Biol 62:373-383
5. Zajchowski DA, Sager R, Webster L 1993 Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res 53:5004-5011
6. Clarke RB, Howell A, Potten CS, Anderson E 1997 Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57:4987-4991
7. Russo J, Ao X, Grill C, Russo IH, Estrogen, progesterone receptor positive cells are not the proliferating cells in the mammary gland. Proceedings of the 89th Annual Meeting of the American Association for Cancer Research, New Orleans, LA, 1998, p 552
8. Jordan VC 1992 The Role of Tamoxifen in the Treatment and Prevention of Breast Cancer. Mosby-Year Book, St. Louis, MO
9. Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS 1996 Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol 10:119-131
10. Webb P, Lopez GN, Uht RM, Kushner PJ 1995 Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443-456
11. Group GC Wisconsin Package, ed 9.1 Genetics Computer Group, Inc., Madison, WI, 1997
12. Kozak M 1996 Interpreting cDNA sequences: some insights from studies on translation. Mamm Genome 7:563-574
13. Inoue S, Orimo A, Hosoi T, Kondo S, Toyoshima H, Kondo T, Ikegami A, Ouchi Y, Orimo H, Muramatsu M 1993 Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein. Proc Natl Acad Sci USA 90:11117-11121
14. Kapp LN, Painter RB, Yu LC, van Loon N, Richard CW, James MR, Cox DR, Murnane JP 1992 Cloning of a candidate gene for ataxia-telangiectasia group D. Am J Hum Genet 51:45-54
15. Reddy BA, Etkin LD 1991 A unique bipartite cysteine-histidine motif defines a subfamily of potential zinc-finger proteins. Nucleic Acids Res 19:6330
16. LeDouarin B, Zechel C, Gamier JM, Lutz Y, Tora L, Pierrat P, Heery P, Gronemeyer H, Chambon P, Losson R 1995 The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14:2020-2033
17. Friedman JR, Fredericks WJ, Jensen DE, Speicher DW, Huang XP, Neilson EG, Rauscher Jr F 1996 KAP-1, a novel corepressor for the highly conserved KRAB repression domain. Genes Dev 10:2067-2078
18. Lupas A 1996 Prediction and analysis of coiled-coil structures. Methods Enzymol 266:513-525
19. Freemont PS 1993 The RING finger. A novel protein sequence motif related to the zinc finger. Ann NY Acad Sci 684:174-192
20. Henry J, Ribouchon MT, Offer C, Pontarotti P 1997 B30.2-like domain proteins: a growing family. Biochem Biophys Res Commun 235:162-165
21. Vernet C, Boretto J, Mattei MG, Takahashi M, Jack LJ, Mather IH, Rouquier S, Pontarotti P 1993 Evolutionary study of multigenic families mapping close to the human MHC class I region. J Mol Evol 37:600-612
22. Reddy BA, Kloc M, Etkin L 1991 The cloning and characterization of a maternally expressed novel zinc finger nuclear phosphoprotein (xnf7) in Xenopus laevis. Dev Biol 148:107-116
23. Cao T, Shannon M, Handel MA, Etkin LD 1996 Mouse ret finger protein (rfp) proto-oncogene is expressed at specific stages of mouse spermatogenesis. Dev Genet 19:309-320
24. Mu ZM, Chin KV, Uu JH, Lozano G, Chang KS 1994 PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol 14:6858-6867
25. Patarca R, Freeman GJ, Schwartz J, Singh RP, Kong QT, Murphy E, Anderson Y, Sheng FY, Singh P, Johnson KA, Guarnagia SM, Durfee T, Blattner F, Cantor H 1988 rpt-1, an intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type I. Proc Natl Acad Sci USA 85:2733-2737
26. Tissot C, Mechti N 1995 Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J Biol Chem 270:14891-14898
27. Chan EK, Di Donato F, Hamel JC, Tseng CE, Buyon JP 1995 52-kD SS-A/Ro: genomic structure and identification of an alternatively spliced transcript encoding a novel leucine zipper-minus autoantigen expressed in fetal and adult heart. J Exp Med 182:983-992
28. Consortium IF 1997 Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 90:797-807
29. Goddard AD, Borrow J, Freemont PS, Solomon E 1991 Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254:1371-1374
30. Takahashi M, Inaguma Y, Hiai H, Hirose F 1988 Developmentally regulated expression of a human "finger"-containing gene encoded by the 5′ half of the ret transforming gene. Mol Cell Biol 8:1853-1856
31. Leonhardt EA, Kapp LN, Young BR, Mumane JP 1994 Nucleotide sequence analysis of a candidate gene for ataxia-telangiectasia group D (ATDC). Genomics 19: 130-136
32. Henry J, Ribouchon M, Depetris D, Mattei M, Offer C, Tazi-Ahnini R, Pontarotti P 1997 Cloning, structural analysis, and mapping of the B30 and B7 multigenic families to the major histocompatibility complex (MHC) and other chromosomal regions. Immunogenetics 46:383-395
33. Campbell IG, Nicolai HM, Foulkes WD, Senger G, Stamp GW, Allan G, Boyer C, Jones K, Bast Jr RC, Solomon E 1994 A novel gene encoding a B-box protein within the BRCA1 region at 17q21.1. Hum Mol Genet 3:589-594
34. Ghadessy FJ, Chen D, Kini RM, Chung MCM, Jeyaseelan K, Khoo HE, Yuen R 1996 Stonustoxin is a novel lethal factor from stonefish (Synanceja horrida) venom. cDNA cloning and characterization. J Biol Chem 271:25575-25581
35. Ishii T, Aoki N, Noda A, Adachi T, Nakamura R, Matsuda T 1995 Carboxy-terminal cytoplasmic domain of mouse butyrophilin specifically associates with a 150-kDa protein of mammary epithelial cells and milk fat globule membrane. Biochim Biophys Acta 1245:285-292
36. Orimo A, Inoue S, Ikeda K, Noji S, Muramatsu M 1995 Molecular cloning, structure, and expression of mouse estrogen-responsive finger protein Efp. Co-localization with estrogen receptor mRNA in target organs. J Biol Chem 270:24406-24413
37. Li X, Shou W, Kloc M, Reddy BA, Etkin LD 1994 Cytoplasmic retention of Xenopus nuclear factor 7 before the mid blastula transition uses a unique anchoring mechanism involving a retention domain and several phosphorylation sites. J Cell Biol 124:7-17
38. Cao T, Borden KL, Freemont PS, Etkin LD 1997 Involvement of the rfp tripartite motif in protein-protein interactions and subcellular distribution. J Cell Sci 110:1563-1571
39. Brzoska PM, Chen H, Zhu Y, Levin NA, Disatnik MH, Mochly-Rosen D, Murnane JP, Christman MF 1995 The product of the ataxia-telangiectasia group D complementing gene, ATDC, interacts with a protein kinase C substrate and inhibitor. Proc Natl Acad Sci USA 92:7824-7828
40. De Laurenzi V, Rogers GR, Hamrock DJ, Marekov LN, Steinert PM, Compton JG, Markova N, Rizzo WB 1996 Sjogren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene. Nat Genet 12:52-57
41. Timmerman V, Raeymaekers P, De Jonghe P, De Winter G, Swerts L, Jacobs K, Gheuens J, Martin JJ, Vandenberghe A, Van Broeckhoven C 1990 Assignment of the Charcot-Marie-Tooth neuropathy type 1 (CMT 1a) gene to 17p11.2-p12. Am J Hum Genet 47:680-685
42. LeGuern E, Gouider R, Ravise N, Lopes J, Tardieu S, Gugenheim M, Abbas N, Bouche P, Agid Y, Brice A 1996 A de novo case of hereditary neuropathy with liability to pressure palsies (HNPP) of maternal origin: a new mechanism for deletion in 17p11.2? Hum Mol Genet 5:103-106
43. Silander K, Meretoja P, Nelis E, Timmerman V, Van Broeckhoven C, Aula P, Savontaus ML 1996 A de novo duplication in 17p11.2 and a novel mutation in the Po gene in two Dejerine-Sottas syndrome patients. Hum Mutat 8:304-310
44. Greenberg F, Guzzetta V, Montes de Oca-Luna R, Magenis RE, Smith AC, Richter SF, Kondo I, Dobyns WB, Patel PI, Lupski JR 1991 Molecular analysis of the Smith-Magenis syndrome: a possible contiguous-gene syndrome associated with del(17)(p11.2). Am J Hum Genet 49:1207-1218
45. Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I, Chambon P 1989 The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J 8:1981-1986
46. Jiang SY, Langan Fahey SM, Stella AL, McCague R, Jordan VC 1992 Point mutation of estrogen receptor (ER) in the ligand-binding domain changes the pharmacology of antiestrogens in ER-negative breast cancer cells stably expressing complementary DNAs for ER. Mol Endocrinol 6:2167-2174
47. Kushner PJ, Hort E, Shine J, Baxter JD, Greene GL 1990 Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens. Mol Endocrinol 4:1465-1473
48. Gronemeyer H, Meyer ME 1991 Nuclear receptors. Hormones, anti-hormones and regulation of the transcription. Ann Endocrinol Paris 52:335-338
49. Parker MG, Arbuckle N, Dauvois S, Danielian P, White R 1993 Structure and function of the estrogen receptor. Ann NY Acad Sci 684:119-126
50. Green S, Kumar V, Theulaz I, Wahli W, Chambon P 1988 The N-terminal DMA-binding 'zinc finger' of the oestrogen and glucocorticoid receptors determines target gene specificity. EMBO J 7:3037-3044
51. Green S, Chambon P 1987 Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor. Nature 325:75-78
52. Ray A, Prefontaine KE, Ray P 1994 Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem 269:12940-12946
53. Stein B, Yang MX 1995 Repression of the interteukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol 15:4971-4979
54. Umayahara Y, Kawamori R, Watada H, Imano E, Iwama N, Morishima T, Yamasaki Y, Kajimoto Y, Kamada T 1994 Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J Biol Chem 269:16433-16442
55. Blobel GA, Sieff CA, Orkin SH 1995 Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor. Mol Cell Biol 15:3147-3153
56. Elgort MG, Zou A, Marschke KB, Allegretto EA 1996 Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-α1 promoter via a novel sequence. Mol Endocrinol 10:477-487
57. Gaub MP, Bellard M, Scheuer I, Chambon P, Sassone Corsi P 1990 Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex. Cell 63:1267-1276
58. Smith CL, Nawaz Z, O'Malley BW 1997 Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol 11:657-666
59. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS 1986 Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83: 2496-2500
60. Glover J F, Irwin JT, Darbre PD 1988 Interaction of phenol red with estrogenic and antiestrogenic action on growth of human breast cancer cells ZR-75-1 and T-47-D. Cancer Res 48:3693-3697
61. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L 1996 Nuclear receptor coactivators and corepressors. Mol Endocrinol 10:1167-1177
62. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P 1986 Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320:134-139
63. Band V, Sager R 1989 Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc Natl Acad Sci USA 86:1249-1253
64. Liang P, Pardee AB 1992 Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967-971
65. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ 1979 Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 18: 5294-5299
66. Zajchowski D, Band V, Pauzie N, Tager A, Stampfer M, Sager R 1988 Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells. Cancer Res 48:7041-7047
67. Hopp TP, Prickett KS, Price VL, Libby RT, March CJ, Ceretti DP, Urdal DL, Conlon PJ 1988 A short polypeptide marker sequence useful for recombinant protein identification and purification. Bio/Technology 6:1204-1210
68. Harlow E, Lane D 1988 Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
69. Stokke T, Collins C, Kuo W-L, Kowbel D, Shadravan F, Tanner M, Kallioniemi O-P, Pinkel D, Deaven L, Gray JW 1995 A physical map of chromosome 20 established using fluorescence in situ hybridization and digital image analysis. Genomics 26:134-137